Registration Dossier

Administrative data

Description of key information

No carcinogenicity study is required.

Key value for chemical safety assessment

Carcinogenicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Carcinogenicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

No carcinogenicity study is required. There is no concern for mutagenicity or genotoxicity at physiologically relevant levels.

In the available repeated-dose toxicity study there are no indications of non-specific organ damage or chronic inflammation. Available data give no concern on carcinogenic properties of the test substance. Carcinogenicity in humans is not expected.

 


Justification for selection of carcinogenicity via oral route endpoint:
No carcinogenicity study is required. There is no concern for mutagenicity or genotoxicity at physiologically relevant levels. In the available repeated-dose toxicity study there are no indications of non-specific organ damage or chronic inflammation. Available data give no concern on carcinogenic properties of the test substance.

Justification for classification or non-classification